Related Experiment Video
Updated: Jun 3, 2026

Isolating and Incorporating Light-Harvesting Antennas from Diatom Cyclotella Meneghiniana in Liposomes with Thylakoid Lipids
Published on: August 28, 2018
The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds
Kazuo Miyashita1, Sho Nishikawa, Fumiaki Beppu
1Faculty of Fisheries Sciences, Hokkaido University, 3-1-1 Minato, Hakodate, Hokkaido 041-8611, Japan. kmiya@fish.hokudai.ac.jp
Abstract:
Obesity and type 2 diabetes are pathologies with rapidly growing prevalence throughout the world. A few molecular targets offer the most hope for anti-obesity and anti-diabetic therapeutics. One of the keys to success will be the induction of uncoupling protein 1 (UCP1) in abdominal white adipose tissue (WAT) and the regulation of cytokine secretions from both abdominal adipose cells and macrophage cells infiltrated into adipose tissue. Anti-obesity and anti-diabetic effects of fucoxanthin, a characteristic carotenoid found in brown seaweeds, have been reported. Nutrigenomic studies reveal that fucoxanthin induces UCP1 in abdominal WAT mitochondria, leading to the oxidation of fatty acids and heat production in WAT. Fucoxanthin improves insulin resistance and decreases blood glucose levels through the regulation of cytokine secretions from WAT. The key structure of carotenoids for the expression of anti-obesity effect is suggested to be the carotenoid end of the polyene chromophore, which contains an allenic bond and two hydroxyl groups.
Insights
Fucoxanthin, a seaweed carotenoid, shows promise for combating obesity and type 2 diabetes by boosting UCP1 in fat tissue and regulating inflammatory signals. This natural compound aids in fat oxidation and improves insulin sensitivity.
Area of Science:
- Nutritional Science
- Metabolic Disease Research
- Marine Biotechnology
Background:
- Obesity and type 2 diabetes are global health crises with limited therapeutic options.
- Targeting uncoupling protein 1 (UCP1) in white adipose tissue (WAT) and regulating cytokine secretion are key therapeutic strategies.
- Fucoxanthin, a seaweed-derived carotenoid, has demonstrated potential anti-obesity and anti-diabetic effects.
Purpose of the Study:
- To investigate the nutrigenomic mechanisms behind fucoxanthin's anti-obesity and anti-diabetic effects.
- To explore fucoxanthin's role in inducing UCP1 expression and regulating cytokine secretion in adipose tissue.
- To identify key structural features of carotenoids responsible for anti-obesity activity.
Main Methods:
- Nutrigenomic analysis to study gene expression changes induced by fucoxanthin.
- Mitochondrial studies focusing on UCP1 induction in abdominal WAT.
- Analysis of cytokine secretion from adipose and macrophage cells.
- Structure-activity relationship assessment of carotenoids.
Main Results:
- Fucoxanthin induces UCP1 in abdominal WAT mitochondria, promoting fatty acid oxidation and heat production.
- Fucoxanthin improves insulin resistance and lowers blood glucose levels by modulating cytokine secretions.
- The specific carotenoid end structure, featuring an allenic bond and hydroxyl groups, is crucial for anti-obesity effects.
Conclusions:
- Fucoxanthin is a promising natural compound for developing anti-obesity and anti-diabetic therapies.
- UCP1 induction and cytokine regulation in WAT are key mechanisms of fucoxanthin's action.
- Carotenoid structure-activity relationships provide insights for designing novel therapeutic agents.
Related Concept Videos
Other Algae
Red Algae
Green Algae
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Biofuels

